Petros Pharmaceuticals, Inc.
PTPI
$0.01
$0.000.81%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.57% | -17.93% | -61.24% | -75.41% | 62.79% |
| Total Depreciation and Amortization | -20.29% | -60.69% | -73.90% | -80.46% | -76.82% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 78.11% | 128.95% | 432.38% | 364.09% | -288.56% |
| Change in Net Operating Assets | 70.04% | 2,714.06% | 49.57% | 187.44% | 205.04% |
| Cash from Operations | 17.03% | 50.86% | 60.96% | 65.87% | 15.98% |
| Capital Expenditure | 71.73% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 71.73% | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 100.00% | 100.00% | 100.00% | 70.64% |
| Issuance of Common Stock | -- | -41.95% | -41.95% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | 79.03% | 20.01% | -63.85% | -211.88% | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.50% | -- | -- | -- |
| Cash from Financing | 185.28% | -52.51% | -73.74% | -160.67% | -159.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.46% | -284.18% | -111.73% | -346.17% | -307.35% |